Startup Magnet Biomedicine Attracts $50M to Expand Scope of Molecular Glue Drugs

A VPN is an essential component of IT security, whether you’re just starting a business or are already up and running. Most business interactions and transactions happen online and VPN

Magnet Biomedicine builds on decades of molecular glue research from its scientific co-founder, Harvard University Professor Stuart Schreiber. The startup is developing drugs that take these glues beyond the biotech industry’s current focus on targeted protein degradation.

Leave a Replay

Sign up for our Newsletter

Contact Us